QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$132.73
+0.2%
$141.19
$96.80
$151.58
$38.90B1.111.59 million shs1.30 million shs
Illumina, Inc. stock logo
ILMN
Illumina
$117.43
+0.6%
$133.78
$89.00
$229.58
$18.70B1.191.76 million shs1.40 million shs
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$1,188.54
-0.3%
$1,269.34
$928.49
$1,577.91
$25.42B1.15141,415 shs100,804 shs
10x Genomics, Inc. stock logo
TXG
10x Genomics
$27.94
-3.5%
$40.19
$26.75
$63.57
$3.33B1.91.46 million shs2.02 million shs
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
-1.57%-8.66%-10.17%+0.94%-4.67%
Illumina, Inc. stock logo
ILMN
Illumina
-1.35%-10.72%-12.37%-14.12%-49.62%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
-0.46%-9.08%-8.45%-0.62%-25.42%
10x Genomics, Inc. stock logo
TXG
10x Genomics
-0.72%-20.36%-22.66%-30.74%-47.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
4.0791 of 5 stars
2.33.01.73.72.20.82.5
Illumina, Inc. stock logo
ILMN
Illumina
4.5603 of 5 stars
3.23.00.04.22.73.31.9
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
3.6713 of 5 stars
1.15.00.03.32.22.52.5
10x Genomics, Inc. stock logo
TXG
10x Genomics
4.2126 of 5 stars
3.42.00.04.82.43.30.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
2.59
Moderate Buy$141.296.45% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.32
Hold$167.7042.81% Upside
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
2.17
Hold$1,233.253.76% Upside
10x Genomics, Inc. stock logo
TXG
10x Genomics
2.89
Moderate Buy$60.22115.54% Upside

Current Analyst Ratings

Latest A, MTD, ILMN, and TXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$60.00 ➝ $55.00
4/10/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$125.00 ➝ $135.00
4/10/2024
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$85.00 ➝ $100.00
4/10/2024
Illumina, Inc. stock logo
ILMN
Illumina
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$170.00
4/10/2024
10x Genomics, Inc. stock logo
TXG
10x Genomics
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $45.00
4/9/2024
Illumina, Inc. stock logo
ILMN
Illumina
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$253.00
4/5/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$145.00 ➝ $163.00
4/4/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$132.00 ➝ $145.00
4/4/2024
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$1,200.00 ➝ $1,300.00
3/26/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$67.00 ➝ $90.00
3/20/2024
Illumina, Inc. stock logo
ILMN
Illumina
OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Mixed
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$6.83B5.69$6.34 per share20.94$19.98 per share6.64
Illumina, Inc. stock logo
ILMN
Illumina
$4.50B4.15$3.56 per share33.01$36.18 per share3.25
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$3.79B6.71$44.18 per share26.90($6.98) per share-170.28
10x Genomics, Inc. stock logo
TXG
10x Genomics
$618.73M5.38N/AN/A$6.22 per share4.49

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.24B$4.2031.6021.834.0718.35%27.09%14.66%5/28/2024 (Estimated)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.16B-$7.34N/A49.13N/A-25.78%2.20%1.25%5/2/2024 (Confirmed)
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$788.78M$35.8933.1226.663.2720.82%-904.59%24.93%5/9/2024 (Confirmed)
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$255.10M-$2.17N/AN/AN/A-41.17%-28.82%-22.67%4/30/2024 (Confirmed)

Latest A, MTD, ILMN, and TXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$7.63N/A-$7.63N/AN/AN/A  
5/2/2024N/A
Illumina, Inc. stock logo
ILMN
Illumina
$0.03N/A-$0.03N/AN/AN/A  
4/30/2024N/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.46N/A+$0.46N/AN/AN/A  
2/27/2024Q1 24
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$1.22$1.29+$0.07$1.40$1.59 billion$1.66 billion    
2/15/2024Q4 2023
10x Genomics, Inc. stock logo
TXG
10x Genomics
-$0.36-$0.41-$0.05-$0.41$182.73 million$183.98 million    
2/9/2024Q4 2023
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
$10.32$9.40-$0.92$10.28$959.45 million$934.90 million      
2/8/2024Q4 23
Illumina, Inc. stock logo
ILMN
Illumina
$0.0130$0.14+$0.1270$1.39$1.09 billion$1.12 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
$0.940.71%+19.04%22.38%1 Years
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
N/AN/AN/AN/AN/A
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest A, MTD, ILMN, and TXG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/21/2024
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
Quarterly$0.23600.72%4/1/20244/2/20244/24/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
0.41
2.68
2.04
Illumina, Inc. stock logo
ILMN
Illumina
0.26
1.66
1.29
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
N/A
1.04
0.71
10x Genomics, Inc. stock logo
TXG
10x Genomics
N/A
4.69
4.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
89.42%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
95.07%
10x Genomics, Inc. stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
N/A
Illumina, Inc. stock logo
ILMN
Illumina
0.17%
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
1.94%
10x Genomics, Inc. stock logo
TXG
10x Genomics
10.65%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
18,100293.05 millionN/AOptionable
Illumina, Inc. stock logo
ILMN
Illumina
9,300159.26 million158.98 millionOptionable
Mettler-Toledo International Inc. stock logo
MTD
Mettler-Toledo International
17,30021.39 million20.97 millionOptionable
10x Genomics, Inc. stock logo
TXG
10x Genomics
1,259119.17 million106.48 millionOptionable

A, MTD, ILMN, and TXG Headlines

SourceHeadline
10x Genomics (NASDAQ:TXG) Shares Gap Down  on Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down on Analyst Downgrade
americanbankingnews.com - April 19 at 1:14 AM
Bruker to acquire Nanostring for $393MBruker to acquire Nanostring for $393M
medtechdive.com - April 18 at 3:02 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down  Following Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down Following Analyst Downgrade
marketbeat.com - April 18 at 10:35 AM
10x Genomics (NASDAQ:TXG) PT Lowered to $55.0010x Genomics (NASDAQ:TXG) PT Lowered to $55.00
marketbeat.com - April 18 at 8:34 AM
10x Genomics, Inc. (TXG)10x Genomics, Inc. (TXG)
finance.yahoo.com - April 17 at 12:34 PM
10x Genomics (NASDAQ:TXG) Trading Down 5.9%10x Genomics (NASDAQ:TXG) Trading Down 5.9%
marketbeat.com - April 16 at 1:41 PM
10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.10x Genomics, Inc. (NASDAQ:TXG) Shares Bought by Sumitomo Mitsui Trust Holdings Inc.
marketbeat.com - April 16 at 7:22 AM
SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)SVB Wealth LLC Has $80.95 Million Position in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 15 at 10:06 PM
10x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.4710x Genomics (NASDAQ:TXG) Hits New 52-Week Low at $33.47
marketbeat.com - April 15 at 2:48 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down  After Analyst Downgrade10x Genomics (NASDAQ:TXG) Shares Gap Down After Analyst Downgrade
americanbankingnews.com - April 12 at 5:26 AM
Cathie Woods ARK focuses on Teladoc and 10X Genomics stockCathie Wood's ARK focuses on Teladoc and 10X Genomics stock
investing.com - April 11 at 7:21 PM
10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 by Analysts at Barclays10x Genomics (NASDAQ:TXG) Price Target Cut to $45.00 by Analysts at Barclays
americanbankingnews.com - April 11 at 4:58 AM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
finance.yahoo.com - April 10 at 7:03 PM
10x Genomics (NASDAQ:TXG) Price Target Cut to $45.0010x Genomics (NASDAQ:TXG) Price Target Cut to $45.00
marketbeat.com - April 10 at 4:19 PM
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 202410x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024
prnewswire.com - April 10 at 4:05 PM
10x Genomics (NASDAQ:TXG) Shares Gap Down to $37.3710x Genomics (NASDAQ:TXG) Shares Gap Down to $37.37
marketbeat.com - April 10 at 11:50 AM
Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)Baillie Gifford & Co. Decreases Stock Holdings in 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - April 9 at 12:12 PM
As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?As 10x Launches Visium HD, Will Single Cell Resolution Draw New Customers?
genengnews.com - March 29 at 5:58 PM
ARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG)ARK Investment Management LLC Acquires 1,047,827 Shares of 10x Genomics, Inc. (NASDAQ:TXG)
marketbeat.com - March 28 at 6:39 AM
10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc.10x Genomics, Inc. (NASDAQ:TXG) Shares Acquired by Vanguard Group Inc.
marketbeat.com - March 27 at 4:25 AM
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay
finance.yahoo.com - March 26 at 1:11 PM
10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel10x Genomics, Inc: 10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
finanznachrichten.de - March 23 at 12:22 PM
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel
finance.yahoo.com - March 21 at 4:46 PM
TXG Nov 2024 40.000 putTXG Nov 2024 40.000 put
ca.finance.yahoo.com - March 16 at 2:48 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Agilent Technologies logo

Agilent Technologies

NYSE:A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Illumina logo

Illumina

NASDAQ:ILMN
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Mettler-Toledo International logo

Mettler-Toledo International

NYSE:MTD
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems. The company's retail weighing solutions consist of weighing and software solutions, AI-driven image recognition solution, and automated packaging and labelling solutions for the meat backroom. It serves the life science industry, independent research organizations, and testing labs; food and beverage manufacturers; food retailers; chemical, specialty chemical, and cosmetics companies; food retailers; transportation and logistics, metals, and electronics industries; and the academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is based in Columbus, Ohio.
10x Genomics logo

10x Genomics

NASDAQ:TXG
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.